How companies are chosen for the Loncar Index and ETF.
It's largely market-cap based within a cancer immunotherapy framework.
Brad and his team didn't choose NWBO bc they believed in DCVax. NWBO was included in the initial index because of the market cap at that time. At the first re-weighting of the index, NWBO was dropped because of the market cap.
by the way, I'm good friends with Brad. He doesn't believe in NWBO.